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Unusual Teenage Growing Pains: If the Genes Fit
Kourtney Rudzinski, DO, Rebecca Sharim, MD

Department of Rheumatology, Lehigh Valley Health Network; Allentown, Pa.

Case Presentation

The patient is an 18-year-old male who presents to the office for an
evaluation of joint pain. His past medical history includes ADD,
Asperger’s, and OSA on CPAP. At age 16, he developed pain and
swelling of his right hand after catching a football. He then
developed a mass in that area which was mobile. He went to a hand
surgeon and had it removed; but did not know the pathology results.
Following surgery, he began to have pain in several joints including
left elbow, bilateral wrists, bilateral knees, bilateral ankles, toes and
fingers. He admits to his joints becoming erythematous and swelling.
He has had fluid removed from his knee by orthopedics before, WBC
count was 18,850. His pains have been treated with naproxen in the
past with minimal improvement. Pain is worst in the morning and is
associated with stiffness and improves with activity. He has a family
history of psoriasis, rheumatoid arthritis and gout.
Physical examination reveals tachycardia, normal cardiopulmonary
examination, but musculoskeletal exam reveals limited range of
motion of bilateral elbows, surgical scar over 3rd right MCP, large
subcutaneous nodule overlying left knee, audible crepitus bilateral
knees and left ankle with mild swelling and warmth overlying the
lateral malleolus (Figs 1-3). Patient was sent for laboratory work up;
results are in Table 1 which most notably reveals a significantly
elevated uric acid. Patient was additionally sent for x-ray evaluation
showing severe erosive changes in the carpal bones,
carpometacarpals, and his right 3rd MCP (Figs 4, 5), as well as a large
erosion of the proximal olecranon measuring 2.2 x 1.3 cm (Fig 6).

table 1
LAB TEST
Hemoglobin

Diagnosis and Management

VALUE (REFERENCE
RANGE)

The patient was confirmed to have gout. Records obtained from other
facilities confirmed a tophus on pathology and monosodium urate
intracellular crystals from his prior knee arthrocentesis. Due to patient’s
young age, he was referred for genetic counseling. After evaluation, due
to his gout, mild muscle weakness, and Asperger’s syndrome, he
underwent testing of the PRPS1 gene. He was found to have a variant of
unknown significance (VUS) of the PRPS1 gene on the X chromosome.

11.9 (12.5-17.0 g/dL)

WBC

11.4 (4-10.5 thou/cmm)

Platelet count

511 (140-350 thou/cmm)

Creatinine

1.31 (0.53-1.30 mg/dL)

Calcium

11.7 (8.5-10.1 mg/dL)

Albumin

4.0 (3.5-4.8 g/dL)

Alkaline
phosphatase

133 (35-120 U/L)

AST

32 (<41 U/L)

ALT

75 (<56 U/L)

CCP

<3.0 (<6.0 RU/mL)

RF

<10 (<15 IU/mL)

ANA

Absent

C-reactive protein

39.2 (<7.0 mg/L)

ESR

79 (0-15mm/hr)

Lyme serologies

Negative

HLA B27

Negative

Uric Acid

16.7 (3.5-7.0mg/dL)
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Discussion

Gout in a teenager is exceedingly rare and is typically the result of a
genetic mutation. In our patient, an unclear variant of the
phosphoribosylpyrophosphate synthetase-1 gene was detected.
Mutations of PRPS1 cause super activity of the PRPP synthetase
enzyme which causes hyperuricemia and hyperuricosuria. There is
a severe phenotype with infantile or early childhood onset which can
lead to intellectual disability, and a milder, late-juvenile/early adult
onset. This is inherited in an X-linked fashion, and familial genetic
counseling is advised. Treatment of gout with urate lowering therapy
is recommended but does not affect other aspects of the disorder.
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Patient was started on colchicine and allopurinol (200mg). Uric acid
improved to 6.8 and inflammatory markers normalized but he
developed worsening transaminitis and his allopurinol dose was
reduced to 100mg. Due to persistent elevation in liver enzymes,
allopurinol was discontinued. The patient continued to have synovitis
and large painful tophi. A G6PD was checked and was negative.
Patient was started on methotrexate and authorized for pegloticase
and is currently receiving treatment, however he has been having
mild reactions and may need to try alternate therapies. He will undergo
close monitoring of his joints for stability during treatment, particularly
the left elbow, given his large erosion. He may need orthopedic
intervention in the future.
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